ZA873475B - Sustained release formulations - Google Patents

Sustained release formulations

Info

Publication number
ZA873475B
ZA873475B ZA873475A ZA873475A ZA873475B ZA 873475 B ZA873475 B ZA 873475B ZA 873475 A ZA873475 A ZA 873475A ZA 873475 A ZA873475 A ZA 873475A ZA 873475 B ZA873475 B ZA 873475B
Authority
ZA
South Africa
Prior art keywords
sustained release
release formulations
administered
core
produced
Prior art date
Application number
ZA873475A
Other languages
English (en)
Inventor
Phillips Reginald
Bikkina Krishnayya
U. Kahn Sadath
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of ZA873475B publication Critical patent/ZA873475B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA873475A 1986-06-06 1987-05-14 Sustained release formulations ZA873475B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/871,643 US4816264A (en) 1986-06-06 1986-06-06 Sustained release formulations

Publications (1)

Publication Number Publication Date
ZA873475B true ZA873475B (en) 1987-11-05

Family

ID=25357834

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA873475A ZA873475B (en) 1986-06-06 1987-05-14 Sustained release formulations

Country Status (17)

Country Link
US (1) US4816264A (de)
EP (1) EP0248447B1 (de)
JP (1) JPS6345216A (de)
KR (1) KR880000088A (de)
AT (1) ATE52027T1 (de)
AU (1) AU603803B2 (de)
CA (1) CA1307205C (de)
DE (1) DE3762309D1 (de)
DK (1) DK288987A (de)
ES (1) ES2014275B3 (de)
FI (1) FI872490A7 (de)
GR (1) GR3000439T3 (de)
NO (1) NO872381L (de)
NZ (1) NZ220410A (de)
PH (1) PH24251A (de)
PT (1) PT85019B (de)
ZA (1) ZA873475B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5160743A (en) * 1988-04-28 1992-11-03 Alza Corporation Annealed composition for pharmaceutically acceptable drug
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
FR2630913A1 (fr) * 1988-05-09 1989-11-10 Delalande Sa Comprimes de sel(s) hydrosoluble(s) de diltiazem a liberation programmee et leur procede de fabrication
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
US5047258A (en) * 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
US5017383A (en) * 1989-08-22 1991-05-21 Taisho Pharmaceutical Co., Ltd. Method of producing fine coated pharmaceutical preparation
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
AT397345B (de) * 1990-04-04 1994-03-25 Chemiefaser Lenzing Ag Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
US5175003A (en) * 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
EP0462066A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphes Gemfibrozil
EP0462067A1 (de) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil-Formulierung
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
US5656296A (en) * 1992-04-29 1997-08-12 Warner-Lambert Company Dual control sustained release drug delivery systems and methods for preparing same
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
DE4318375A1 (de) * 1993-05-28 1994-12-01 Rottendorf Pharma Gmbh Mischung zur Schaffung von Filmüberzügen für Tabletten od. dgl.
AU680019B2 (en) * 1993-08-30 1997-07-17 Warner-Lambert Company Llc Tablet coating based on a melt-spun mixture of a saccharide and apolymer
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
KR19980077329A (ko) * 1997-04-18 1998-11-16 이범진 이중층 약물 함유 제어방출성 제제
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
WO2000057838A2 (en) * 1999-03-29 2000-10-05 American Home Products Corporation Coating system
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
GB0002305D0 (en) * 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
DE60123384T2 (de) * 2000-02-04 2007-08-02 DepoMed, Inc., Menlo Park Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
US6855721B1 (en) 2000-07-28 2005-02-15 Indevus Pharmaceuticals, Inc. Methods and compositions for alleviating stuttering
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US8685427B2 (en) * 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US20040213850A1 (en) * 2003-04-25 2004-10-28 Eleni Dokou Sustained release delivery of a thrombin inhibitor
MXPA06003813A (es) * 2003-10-10 2006-06-14 Lifecycle Pharma As Forma solida de dosificacion que comprende un fibrato y una estatina.
CA2540984C (en) 2003-10-10 2011-02-08 Lifecycle Pharma A/S A solid dosage form comprising a fibrate
MXPA06012564A (es) * 2004-04-27 2007-01-31 Medicinova Inc Derivados de acido fenoxialquilcarboxilico en el tratamiento de enfermedades inflamatorias.
JP4805256B2 (ja) * 2004-05-14 2011-11-02 グリーン・クロス・コーポレイション 右旋性モルヒナンの神経保護特性
US7497627B2 (en) * 2004-06-07 2009-03-03 Honeywell International Inc. Thrust bearing
JP2007092994A (ja) * 2005-09-02 2007-04-12 Shimadzu Corp 動圧気体軸受
WO2007143163A2 (en) * 2006-06-01 2007-12-13 Schering Corporation Pharmaceutical compositions for sustained release of phenyephrine
WO2007143158A2 (en) * 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20080075766A1 (en) * 2006-09-25 2008-03-27 Shun-Por Li Multi-core dosage form having transparent outer coating
EP2496219A1 (de) * 2009-06-29 2012-09-12 McNeil-PPC, Inc. Pharmazeutische tablette mit flüssigkeitsgefüllter kapsel
USRE48269E1 (en) 2011-08-01 2020-10-20 Ntn Corporation Thrust foil bearing
US8962687B2 (en) 2012-12-05 2015-02-24 Medicinova, Inc. Method of treating liver disorders
US8835499B2 (en) 2011-12-08 2014-09-16 Medicinova, Inc. Method of treating non-alcoholic fatty liver disease and steatohepatitis
BR112016001400B1 (pt) 2013-07-25 2023-02-28 Medicinova, Inc Uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade
US20150321989A1 (en) 2014-05-08 2015-11-12 Medicinova, Inc. Method of treating idiopathic pulmonary fibrosis
US9346754B2 (en) 2014-05-08 2016-05-24 Medicinova, Inc. Method of treating advanced non-alcoholic steatohepatitis
JP6469727B2 (ja) 2014-06-02 2019-02-13 メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． 線維症の抑制又は治療方法
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
KR102462638B1 (ko) 2014-11-26 2022-11-03 메디시노바, 인크. 이부딜라스트와 릴루졸의 배합물 및 이의 사용방법
KR20200110317A (ko) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 결정형 및 이의 제조 방법
BR112020011189A2 (pt) 2017-12-05 2020-11-17 Sunovion Pharmaceuticals Inc. misturas não racêmicas e usos das mesmas
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CA3142355A1 (en) 2019-06-04 2020-12-10 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
CA3217719A1 (en) 2021-05-28 2022-12-01 Kazuko Matsuda Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1568837A (en) * 1975-10-10 1980-06-04 Squibb & Sons Inc Controlled release tablet
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS5867616A (ja) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd 腸溶性マイクロカプセル
US4434153A (en) * 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
CH666405A5 (de) * 1985-06-24 1988-07-29 Ciba Geigy Ag Feste, haltbare darreichungsformen mit elastischem filmueberzug.

Also Published As

Publication number Publication date
ATE52027T1 (de) 1990-05-15
PT85019A (en) 1987-07-01
DK288987D0 (da) 1987-06-04
PH24251A (en) 1990-05-04
FI872490A0 (fi) 1987-06-03
US4816264A (en) 1989-03-28
FI872490L (fi) 1987-12-07
NO872381D0 (no) 1987-06-05
PT85019B (pt) 1990-03-08
EP0248447A2 (de) 1987-12-09
DE3762309D1 (de) 1990-05-23
CA1307205C (en) 1992-09-08
AU7369287A (en) 1987-12-10
NZ220410A (en) 1990-05-28
FI872490A7 (fi) 1987-12-07
EP0248447A3 (en) 1988-04-13
ES2014275B3 (es) 1990-07-01
AU603803B2 (en) 1990-11-29
DK288987A (da) 1987-12-07
GR3000439T3 (en) 1991-06-28
KR880000088A (ko) 1988-03-23
JPS6345216A (ja) 1988-02-26
EP0248447B1 (de) 1990-04-18
NO872381L (no) 1987-12-07

Similar Documents

Publication Publication Date Title
ZA873475B (en) Sustained release formulations
US5525634B1 (en) Colonic drug delivery system
AU5087290A (en) Transmembrane formulations for drug administration
AU8933391A (en) Medical drug formulation and delivery system
ZA915584B (en) Drug delivery system involving interaction between protein or polypeptide and hydrophobic biodegradable polymer
AU1099288A (en) Drug delivery system and method of making the same
GB2231495B (en) Enhanced uptake drug delivery system
GB2185397B (en) Drug delivery system
AU7333287A (en) Controlled release of macromolecular polypeptides
AU6820687A (en) Drug delivery system
EP0707471A4 (de) Neue verabreichungssysteme für wirkstoffe
EP0637946A4 (de) Implantierbares abgabesystem für gewebespezifische, therapeutische mittel.
EP0674528A4 (de) Arzneistoffabgabesystem auf der basis von cyclodextrin und einem polymer.
PT80525B (en) Sustained release drug delivery device
AU660290B2 (en) Multiple drug delivery system
AU6442290A (en) Recorded message delivery system
GB8901833D0 (en) Pharmaceutical formulations with controlled drug release
EP0659077A4 (de) Pilocarpin-abgabesystem mit kontrollierter freisetzung.
IE872372L (en) Drug delivery system using a block copolymer.
PH31166A (en) Polymeric drug delivery system.
GB8906081D0 (en) Oxygen administration systems
GB8816351D0 (en) Sustained drug release system
GB8816352D0 (en) Sustained drug release system
IE882774L (en) Trans-mucosal drug delivery formulations
ZA897603B (en) Novel drug delivery system